{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:24:39Z","timestamp":1790083479240,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"IDIQ","award":["HHSN272201000011I"],"award-info":[{"award-number":["HHSN272201000011I"]}]},{"DOI":"10.13039\/100015691","name":"DMID","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002832","name":"CIMA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002832","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIBERehd Instituto de Salud Carlos III"},{"DOI":"10.13039\/100002327","name":"SAF","doi-asserted-by":"publisher","award":["SAF2009-08524"],"award-info":[{"award-number":["SAF2009-08524"]}],"id":[{"id":"10.13039\/100002327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002327","name":"SAF","doi-asserted-by":"publisher","award":["SAF2012-39578"],"award-info":[{"award-number":["SAF2012-39578"]}],"id":[{"id":"10.13039\/100002327","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Department of Science, Fondo de Investigaci\u00f3n Sanitaria","award":["FIS PI10\/00264"],"award-info":[{"award-number":["FIS PI10\/00264"]}]},{"name":"Spanish Department of Science, Fondo de Investigaci\u00f3n Sanitaria","award":["PI13\/00207"],"award-info":[{"award-number":["PI13\/00207"]}]}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jhep.2015.02.048","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T17:34:34Z","timestamp":1426181674000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I"],"prefix":"10.1016","volume":"63","author":[{"given":"Pedro","family":"Berraondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Di Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Korolowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linta M.","family":"Thampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Otano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Ardaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar V.","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin D.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Menne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gonz\u00e1lez-Aseguinolaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.02.048_b0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.26516","article-title":"Chronic hepatitis B infection: a global disease requiring global strategies","volume":"58","author":"Ioannou","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.048_b0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.26383","article-title":"Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing","volume":"58","author":"Rodriguez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.048_b0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"EASL","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.048_b0020","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.24306","article-title":"Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties","volume":"53","author":"Fioravanti","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.048_b0025","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.4049\/jimmunol.1101598","article-title":"The fusion protein of IFN-alpha and apolipoprotein A-I crosses the blood-brain barrier by a saturable transport mechanism","volume":"188","author":"Fioravanti","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2015.02.048_b0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3748\/wjg.v13.i1.104","article-title":"The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection","volume":"13","author":"Menne","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.02.048_b0035","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/JVI.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2015.02.048_b0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.10221","article-title":"The woodchuck interferon-alpha system: Cloning, family description, and biologic activity","volume":"68","author":"Berraondo","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.02.048_b0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymthe.2005.02.017","article-title":"IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes","volume":"12","author":"Berraondo","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2015.02.048_b0050","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/jmv.22104","article-title":"Characterization of woodchuck apolipoprotein A-I: a new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model","volume":"83","author":"Fioravanti","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.02.048_b0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1525-0016(03)00095-9","article-title":"Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6","volume":"7","author":"Grimm","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2015.02.048_b0060","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1128\/AAC.00654-08","article-title":"Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection","volume":"52","author":"Menne","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2015.02.048_b0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/vim.1993.6.161","article-title":"New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection","volume":"6","author":"Cote","year":"1993","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jhep.2015.02.048_b0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1572-0241.2006.01006.x","article-title":"Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B","volume":"102","author":"Sarin","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.02.048_b0075","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jhep.2015.02.048_b0080","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2036.2005.02453.x","article-title":"The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation","volume":"21","author":"van Zonneveld","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.02.048_b0085","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.048_b0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/hum.2006.17.601","article-title":"Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction","volume":"17","author":"Berraondo","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jhep.2015.02.048_b0095","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.048_b0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"Lancet Neurol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815001713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815001713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T19:53:21Z","timestamp":1598817201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815001713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0168827815001713"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.02.048","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}